Analysis of cheek swabs taken from pregnant women revealed a potential epigenetic biomarker for preeclampsia, a potentially life-threatening condition that often leads to preterm births.
Astellas Acquires Eye-Disease Specialist Iveric for Almost $6B
Credit: FG Trade/Getty Images Astellas is acquiring Iveric Bio for approximately $5.9 billion, making Iveric a wholly-owned subsidiary. The purchase price, $40.00 per share, represents